Model improves disease prediction by tracking genetic risk with age
Across 28 diseases, median scores for distinguishing future cases from others were 0.95 versus 0.92 for a model keeping common genetic effects constant with age.
Our read
AI & data- Studied:
- Preprint: computational study of biobank participants, against model with age-constant polygenic effects
- What changed:
- Distinguishing future disease cases improved: median scores were 0.95 versus 0.92 for a model keeping genetic effects constant with age
- The catch:
- Tests measured prediction accuracy, not whether using the model improves patient care
- In the record:
- The 23rd paper on BRCA1 with results in people; 229 on record in all.
Editor of record: Boris Djordjevic · AgingResearch.News
Human health records from three biobanks supplied data for testing Mendelnoulli, a longitudinal model of inherited genetic variation and disease over time. The analysis covered 348 diseases, 36 scores combining the effects of many genetic variants, and 34 single-gene conditions. The model separated overall disease accumulation from a person’s tendency to develop particular diseases.
In records held back for testing, Mendelnoulli better distinguished new cases over one year for all 28 diseases tested than a model keeping common genetic effects constant with age. Among people with no prior diagnoses, it identified 8.6 more of every 100 new cases than the comparison model when both flagged the 5% at highest risk.
Why it matters
Inherited variation is fixed at birth, but its health effects can change with age. The model offers a unified way to study when common and rare genetic influences relate to disease across a lifetime.
Caveats
Prediction tests using biobank health records do not show whether using the model would improve care. The work is a preprint and has not been peer-reviewed.
The paper
How inherited variation shapes human disease trajectories
Massachusetts General Hospital
medRxiv, Nov 13, 2026, Open access, CC BY-NC-ND, Preprint, not yet peer-reviewed
Comments
Be the first to comment.